[Pharmacology and clinical effects of lidoflazine].
D000081:Acetamides / Q000494:pharmacology / Q000627:therapeutic use; D000227:Adenine Nucleotides / Q000378:metabolism; D000787:Angina Pectoris / Q000188:drug therapy; D000818:Animals; D002986:Clinical Trials as Topic; D003250:Constriction; D003327:Coronary Disease / Q000188:drug therapy; D003331:Coronary Vessels / Q000187:drug effects / Q000473:pathology; D004285:Dogs; D006321:Heart / Q000502:physiology; D006801:Humans; D009206:Myocardium / Q000378:metabolism; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use; D013552:Swine; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use; D014992:Xylenes / Q000494:pharmacology / Q000627:therapeutic use
D000081:Acetamides; D000227:Adenine Nucleotides; D010879:Piperazines; D014665:Vasodilator Agents; D014992:Xylenes
Pharmacologie et effets cliniques de la lidoflazine.